Skip to main content
Log in

Calcium-mediated signal transduction: biology, biochemistry, and therapy

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

The process of proliferation, invasion and metastasis is a complex one which involves both the autonomy of the malignant cells and their interaction with the cellular and extracellular environments. The way in which the tumor cells respond to cellular and extracellular stimuli is regulated through transduction of those signals and translation into cellular activity. Transmembrane signal transduction involves three major categories of events: ion channel activation, transmission through guanine nucleotide binding protein intermediates with production of second messengers, and phosphorylation events. A frequent common denominator of these different pathways is a cellular calcium homeostasis. Calcium may be both a result of and a regulator of many of these signal transduction pathways and has been shown to have a role in the regulation of proliferation, invasion, and metastatic potential. The understanding and application of the basic tenets of these pathways to tumor cell proliferation, invasion, and metastases opens a new target for therapeutic intervention. We have identified a novel agent, CAI, which through inhibition of stimulated calcium influx inhibits proliferation and migrationin vitro, and growth and dissemination in human cancer xenograftsin vivo. CAI offers a new approach to cancer therapy, signal transduction therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

G protein:

Guanine nucleotide binding protein

CAI:

Carboxyamido-triazole

EGF:

Epidermal Growth Factor

References

  1. Cancer statistics. CA Journal 43: 1–19, 1993

    Google Scholar 

  2. Reeve JG: Mitogenesis and the search for new targets for anticancer drug design. Tumor Biol 12: 1–8, 1991

    Google Scholar 

  3. Moffet AS: Going back to the future with small synthetic compounds. Science 260: 910–912, 1993

    Google Scholar 

  4. Spiegel AM: G proteins in clinical medicine. Hosp Practice, June 15: 1988

  5. Tang WJ, Gilman AG: Adenylyl cyclases. Cell 70: 869–872, 1992

    Google Scholar 

  6. Freissmuth M, Casey PJ, Gilman AG: G proteins control diverse pathways of transmembrane signaling. FASEB J 3: 2125–2131, 1989

    Google Scholar 

  7. Rosenthal W, Hescheler J, Trautwein W, Schultz G: Control of voltage-dependent Ca2+ by G protein-coupled receptors. FASEB J 2: 2784–2790, 1988

    Google Scholar 

  8. Neer EJ, Clapham DE: Roles of G protein subunits in transmembrane signalling. Nature 333: 129–134, 1988

    Google Scholar 

  9. Simon MI, Strathmann MP, Gautam N: Diversity of G proteins in signal transduction. Science 252: 802–808, 1991

    Google Scholar 

  10. Conklin BR, Bourne HR: Structural elements of Gα subunits that interact with Gβγreceptors, and effectors. Cell 73: 631–641, 1993

    Google Scholar 

  11. Aaronson SA: Growth factors and cancer. Science 254: 1146–1153, 1991

    Google Scholar 

  12. Pelech SL, Sanghera: MAP kinases: charting the regulatory pathways. Science 257: 1355–1356, 1992

    Google Scholar 

  13. Lin LL, Wartmann M, Lin AY, Knopt JL, Seth A, davis RJ: cPLA2 is phosphorylated and activated by MAP kinase. Cell 72: 269–278, 1993

    Google Scholar 

  14. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD: Molecular biology of the cell. Second edition. Garland Publishing Inc., NY: 706–708, 1989

    Google Scholar 

  15. Tanaguchi T, Kitagawea H, Yasua S,et al. Protein-tyrosine kinase p72syk is activated by thrombin and is negatively regulated through Ca2+ regulation in platelets. J Biol Chem 268: 2277–2279, 1993

    Google Scholar 

  16. Rhee SG, Suh P-G, Ryu S-H, Lee SY: Studies of inositol phospholipid-specific phospholipase C. Science 244: 546–550, 1989

    Google Scholar 

  17. Neher E: Ion channel for communication between and within cells. Science 256: 498–502, 1992

    Google Scholar 

  18. Brown AM, Birnbaumer L: Ionic channels and their regulation by G protein subunits. Annu Rev Physiol 52: 197–213, 1990

    Google Scholar 

  19. Rink TJ: Receptor-mediated calcium entry. FEBS Lett 268: 381–385, 1990

    Google Scholar 

  20. Meldolesi J, Clementi E, Fusolato C, Zacchetti D, Pozzan T. Ca2+ influx following receptor activation. Trends Pharmacol Sci 12: 289–292, 1991

    Google Scholar 

  21. Berridge M: Inositol triphosphate and diacylglycerol: two interacting second messengers. Ann Rev Biochem 56: 159–193, 1987

    Google Scholar 

  22. Irvine RF: Inositol phosphates and Ca2+ entry: toward a proliferation or a simplification. FASEB J 6: 3085–3091, 1992

    Google Scholar 

  23. Berridge MJ, Irvine RF: Inositol phosphates and cell signalling. Nature 341: 197–205, 1989

    Google Scholar 

  24. Klee CB: Ca++ dependent phospholipid (and membrane) binding proteins. Biochemistry 27: 6645–6653, 1988

    Google Scholar 

  25. Bell RM: Protein kinase C activation by diacylglycerol second messengers. Cell 45: 631–632, 1986

    Google Scholar 

  26. Marnett LJ: Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52: 5575–5589, 1992

    Google Scholar 

  27. Julius D, Livelli TJ, Jessell TM, Axel R: Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. Science 244: 1057–1061, 1989

    Google Scholar 

  28. Allen LF, Lefkowitz RJ, Caron MG, Cotecchia S: G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the α1-B-adrenergic receptor enhances mitogenesis and tumorigenicity. Proc Natl Acad Sci USA 88: 11354–11358, 1991

    Google Scholar 

  29. Gutkind JS, Novotny EA, Brann MR, Robbins KC: Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. Proc Natl Acad Sci USA 88: 4703–4707, 1991

    Google Scholar 

  30. Felder CC, Dieter P, Kinsella J, Tamura K, Kanterman RY, Axelrod J: A transfected m5 muscarinic acetylcholine receptor stimulates phospholipase A2 by inducing both calcium influx and activation of protein kinase C. J Pharm Exp Ther 255: 1140–1147, 1990

    Google Scholar 

  31. Felder CC, Poulter MO, Wess J: Muscarinic receptor-operated CA2+ influx in transfected fibroblast cell is independent of inositol phosphates and release of intracellular Ca2+. Proc Natl Acad Sci USA 89: 509–213, 1992

    Google Scholar 

  32. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L: GTPase inhibiting mutation activates the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340: 692–696, 1989

    Google Scholar 

  33. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, Duh Q-Y, Clark OH, Kawasaki E, Bourne HR, McCormick F: Two G protein oncogenes in human endocrine tumors. Science 250: 655–659, 1990

    Google Scholar 

  34. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Soltoff S: Oncogenes and signal transduction. Cell 64: 281–302, 1991

    Google Scholar 

  35. Fleischman LF, Chawala SB, Cantley L: Ras-transformed cells: Altered levels of phosphatidylinositol-4,5-bisphosphate and catabolites. Science 231: 407–410, 1986

    Google Scholar 

  36. Sethi T, Langdon S, Smyth J, Rozengurt E: Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonistsin vitro andin vivo. Cancer Res 52: 2737s-2742s, 1992

    Google Scholar 

  37. Moody TW, Cuttitta F: Growth factor and peptide receptors in small cell lung cancer. Life Sciences 52: 1161–1173, 1993

    Google Scholar 

  38. Imoto M, Sujikai I, Hideaki U, Umezawa K: Involvement of tyrosine kinase in growth factor-induced phospholipase C activation in NIH3T3 cells. Biochim Biophys Acta: 188-172, 1993

  39. Kohn EC, Liotta LA: Invasion and metastasis: new approaches to an old problem. Oncology 7: 47–62, 1993

    Google Scholar 

  40. Liotta LA: Tumor invasion and metastases: role of the extracellular matrix. Rhoads memorial award lecture. Cancer Res 46: 1–7, 1986

    Google Scholar 

  41. Zabrenetzsky V, Gallin EK: Inositol 1,4,5-trisphosphate concentrations increase after adherence in the macrophagelike cell line J 774.1. Biochem J 255: 1037–1043, 1988

    Google Scholar 

  42. Aznavoorian S, Stracke ML, Krutzsch H, Schiffmann E, Liotta LA: Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells. J Cell Biol 110: 1427–1438, 1990

    Google Scholar 

  43. McCarthy JB, Hagen ST, Furcht LT: Human fibronectin contains distinct adhesion and motility promoting domains for metastatic melanoma cells. J Cell Biol 102: 179–188, 1986

    Google Scholar 

  44. Yamada KM: Cell surface interactions with extracellular materials. Annu Rev Biochem 52: 761–799, 1983

    Google Scholar 

  45. Brown PD, Levy AT, Margulies IMK, Liotta LA, Stetler-Stevenson WG: Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 50: 6184–6191, 1990

    Google Scholar 

  46. Stetler-Stevenson WG, Krutzsch HC, Wacher MPet al.: The activation of human type IV collagenase proenzyme. J Biol Chem 264: 1353–1356, 1989

    Google Scholar 

  47. Kerr LD, Miller DB, Matrisian L: TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a fos binding sequence. Cell 61: 267–278, 1990

    Google Scholar 

  48. Stracke ML, Krutzsch HC, Unsworth EJ, Arestad A, Cioce V, Schiffmann E, Liotta LA: Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem 267: 2524–2529, 1992

    Google Scholar 

  49. Stracke ML, Guirguis R, Liotta LA, Schiffmann E: Pertussis toxin inhibits stimulated motility independently of the adenylate cyclase pathway in human melanoma cells. Biochem Biophys Res Commun 146: 339–345, 1987

    Google Scholar 

  50. Liotta LA, Mandler R, Murano G: Tumor cell autocrine motility factor. Proc Natl Acad Sci USA 83: 3302–3306, 1986

    Google Scholar 

  51. Kohn EC, Liotta LA, Schiffman E: Autocrine motility factor stimulates a three-fold increase in inositol trophosphate in human melanoma cells. Biochem Biophys Res Commun 166: 757–764, 1990

    Google Scholar 

  52. Evans CP, Walsh DS, Kohn EC: An autocrine motility factor secreted by the Dunning R-3327 rat prostatic adenocarcinoma cell subtype AT2.1. Int J Cancer 49: 109–113, 1991

    Google Scholar 

  53. Savarese DMF, Russel JT, Fatatis A, Liotta LA: Type IV collagen stimulates an increase in intracellular calcium: potential role in tumor cell motility. J Biol Chem 267: 21928–21935, 1992

    Google Scholar 

  54. Zabrenetzsky V, Roberts DD: Signal transduction during thrombospondin-stimulated motility of A2058 human melanoma cells. Proc Am Assoc Cancer Res 34: 33, 1993

    Google Scholar 

  55. Minniti CP, Kohn EC, Grubb JH, Sly WS, Oh Y, Muller HL, Rosenfeld RG, Helman LJ: The insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor mediates IGF-II induced motility in human rhabdomyosarcoma cells. J Biol Chem 267: 9000–9004, 1992

    Google Scholar 

  56. Cross M, Exeter MT: Growth factors in development, transformation, tumorigenesis. Cell 64: 271–280, 1991

    Google Scholar 

  57. Egan SE, McClarty GA, Jarolin L, Wright JA, Spiro I, Hager C, Greenberg AH: Expression of H-ras correlates with metastatic potential phenotype in 10T1/2 and NIH 3T3 cells. Mol Cell Biol 7: 830–837, 1987

    Google Scholar 

  58. Folkman J, Shing Y: Angiogenesis. J Biol Chem 267: 10931–10934, 1992

    Google Scholar 

  59. Hauang AJ, Manning JE, Banbak TM, Ratau MC, Hanser KR, Silverstein SC: Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells. J Cell Biol 120: 1371–1380, 1993

    Google Scholar 

  60. Marks PW, Maxfield FR: Transient increases in cytosolic free calcium appears to be required for the migration of adherent human neutrophils. J Cell Biol 110: 43–52, 1990

    Google Scholar 

  61. Mamachi T, Hirata M, Koga T: Origin of intracellular calcium and quantitation of mobilizable calcium in neutrophils stimulated with chemotactic peptide. Biochem Biophys Acta 889: 136–148, 1986

    Google Scholar 

  62. Kohn EC, Francis EA, Liotta LA, Schiffmann E: Heterogeneity of the motility responses in malignant tumor cells: a biological basis for the diversity and homing of metastatic cells. Int J Cancer 46: 287–292, 1990

    Google Scholar 

  63. Lester BR, Weinstein LS, McCarthy JB, Sun Z, Smith RS, Furcht LT: The role of G-proteins in matrix-mediated motility of highly and poorly invasive melanoma cells. Int J Cancer 48: 113–120, 1991

    Google Scholar 

  64. Lester BR, McCarthy JB, Sun Z, Smith RS, Furcht LT, Spiegel AM: G-protein involvement in matrix-mediated motility and invasion of high and low experimental metastatic B16 Melanoma clones. Cancer Res 49: 5940–5948, 1989

    Google Scholar 

  65. Zachary JM, Cleveland G, Kwoch L, Lawrance T, Weissman RM, Nabell L, Fried FA, Staab EV, Risinger MA, Lin S: Actin filament organization of the dunning R3327 rat prostatic adenocarcinoma system: correlation with metastatic potential. Cancer Res 46: 926–932, 1986

    Google Scholar 

  66. Sheth B, Banks P, Burton DR, Monk PN: The regulation of actin polymeration in differentiating U937 cells correlated with increased membrane levels of the pertussis-toxin-sensitive G-protein Gi2. Biochem J 275: 809–811, 1991

    Google Scholar 

  67. Stossel TP: On the crawling of cells. Science 260: 1086–1093, 1993

    Google Scholar 

  68. Cross M, Dexter TM: Growth factors in development, transformation, and tumorgenicity. Cell 64: 271–280, 1991

    Google Scholar 

  69. Kurachi H, Morishige K, Amemiya K, Adichi H, Hirota K, Miyake A, Tanizawa O: Importance of transforming growth factor (alpha)/epidermal growth factor receptor autocrin growth mechanism in an ovarian cancer cell linein vivo. Cancer Res 51: 5956–5959, 1991

    Google Scholar 

  70. Berchuck A, Kamel A, Whitaker R, Kerns B, Olt G, Kinney R, Soper JT, Doge R, Clarke-Pearson DL, Marks P, McKenzie S, Yin S, Bast RC: Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 50: 4087–4091, 1990

    Google Scholar 

  71. Godwin AK, Hamilton TC, Knudson AG: Oncogenes and antioncogenes. Hoskins WJ, Perez CA, Young RC (eds) Principles and Practice of Gynecologic Oncology. J.B. Lippincott Company, Philadelphia, 1992, pp 87–116

    Google Scholar 

  72. DiFiore PP, Segatto O, Taylor WG, Aaronson SA, Pierce JH: EGF erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling. Science 248: 79–83, 1990

    Google Scholar 

  73. Wahl MI, Nishibe S, Suh P-G, Rhe SG, Carpenter G: Epidermal growth factor stimulates tyrosine phosphorolation of phospholipase C-II independently of receptor internalization and extracellular calcium. Proc Natl Acad Sci USA 86: 1568–1572, 1989

    Google Scholar 

  74. Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B, Hynes NE: Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 48: 1238–1243, 1988

    Google Scholar 

  75. Marco ED, Pierce JH, Knicley CL: Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of the ratneu gene. Mol Cell Biol 10: 3247-3252

  76. Chapron Y, Cochet C, Crouzy S, Jullien T, Keramidas M, Verdetti J: Tyrosine protein kinase activity of the EGF receptor is required to induce activation of receptor-operated calcium channels. Biochem Biophys Res Commun 158: 527–533, 1989

    Google Scholar 

  77. Nishibe S, Wahl M, Hermandez-Sotomayor SMT, Tonks NK, Rhee SG, Carpenter G: Increase of the catalitic activity of phospholipase C-γ1 by tyrosine phosphorolation: Science 250: 1253–1256, 1990

    Google Scholar 

  78. Yang L, Camoratto AM, Baffy G, Raj S, Manning DR, Williamson JR: Epidermal growth factor-mediated signaling of Gi-protein to activation of phospholipases in rat-cultured hepatocytes. J Biol Chem 268: 3739–3746, 1993

    Google Scholar 

  79. Kadowaki T, Koyasu S, Nishida E, Tobe K, Izumi T, Takaku F, Sakai H, Yahara I, Kasuga M: Tyrosine phosphorylation of common and specific sets of cellular proteins rapidly induced by insulin, insulin-like growth factor I, and epidermal growth factor in an intact cell. J Biol Chem 262: 7342–7350, 1987

    Google Scholar 

  80. Kojima I, Kitaoka M, Ogata E: Insulin like growth factor 1 stimulates diacylglycerol production via multiple pathways in Balb/c3T3 cells. J Biol Chem 265: 16846–16850, 1990

    Google Scholar 

  81. Kojima I, Mogami H, Shibata H, Ogata E: Role of calcium entry and protein kinase C in the progression activity of insulin-like growth factor-I in balb/c3T3 cells. J Biol Chem 268: 10003–10006, 1993

    Google Scholar 

  82. Egan SE, Wright JA, Jarolim L, Yanagihara K, Bassin RH, Greenberg AH: Transformation by oncogenes encoding protein kinases induces the metastatic phenotype. Science 238: 202–205, 1987

    Google Scholar 

  83. Blay J, Brown KD: Epidermal growth factor promotes the chemotactic migration of cultured rat intestinal epithelial cells. J Cell Physiol 124, 1985

  84. Stracke ML, Kohn EC, Aznnavoorian SA, Wilson LL, Salomon D, Krutzsch HC, Liotta LA: Insulin-like growth factors stimulate chemotaxis in human melanoma cells. Biochem Biophys Res Commun 153: 1076–1083, 1988

    Google Scholar 

  85. Hari J, Pierce SB, Morgan DO, Sara V, Smith MC, Roth R: The receptor for insulin-like growth factor II mediates an insulin-like response. EMBO J 6: 3367–3371, 1987

    Google Scholar 

  86. Tally M, Li CH, Hall K: IGF-2 stimulated growth mediated by the somatomedin type 2 receptor. Biochem Biophys Res Commun 148: 811–816, 1987

    Google Scholar 

  87. Kohn EC, Liotta LA: L651582: A novel antiproliferative and antimetastasis agent. J Nat Cancer Inst 82: 54–60, 1990

    Google Scholar 

  88. Felder CC, Ma AL, Liotta LA, Kohn EC: The antiproliferative and antimetastatic compound L651582 inhibits muscarinic acetylcholine receptor-stimulated calcium influx and arachidonic acid release. J Pharm Exp Ther 257: 967–971, 1991

    Google Scholar 

  89. Kohn EC, Sandeen MA, Liotta LA:In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate and inositol phosphates. Cancer Res 52: 3208–3212, 1992

    Google Scholar 

  90. Pozzatti R, Muschel R, Williams J, Padmanabhan R, Howard B, Liotta L, Khoury G: Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials. Science 232: 223–227, 1986

    Google Scholar 

  91. Bonner TI, Young AC, Brann MR, Buckley NJ: Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron 1: 403–410, 1988

    Google Scholar 

  92. Jones SVP, Murphy TJ, Brann MR: Physiological comparison of cloned muscarinic receptor subtypes expressed in CHO cells. Trends in Pharm Sci 10: 116 (abstract 72), 1989

    Google Scholar 

  93. Gusovsky F, Lueders JE, Kohn EC, Felder CC: Muscarinic receptor-mediated tyrosine phosphorylation of phospholipase C-γ. J Biol Chem 268: 7768–7772, 1993

    Google Scholar 

  94. Felder CC, MacArthur L, Ma AL, Gusovsky F, Kohn EC: Tumor-suppressor function of muscarinic acetylcholine receptors is associated with activation of receptor-operated calcium influx. Proc Natl Acad Sci USA 90: 1706–1710, 1993

    Google Scholar 

  95. Holmes KA, Chaffins S, Osborn BL, Liotta LA, Kohn EC: Quantitation of human plasma levels of the anticancer agent carboxyamidotriazole by high-performance liquid chromatography. J Chromatogr 613: 317–325, 1993

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cole, K., Kohn, E. Calcium-mediated signal transduction: biology, biochemistry, and therapy. Cancer Metast Rev 13, 31–44 (1994). https://doi.org/10.1007/BF00690417

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00690417

Key words

Navigation